Clinical-genomic characteristics in patients with EGFR-mutated non-small cell lung cancer harboring MET copy number gains after progression on EGFR-TKI: A report from LC-SCRUM-TRY.

Authors

null

Tsuyoshi Hirata

National Cancer Center Hospital East, Kashiwa, Japan

Tsuyoshi Hirata , Hiroki Izumi , Shingo Matsumoto , Kazumi Nishino , Terufumi Kato , Masahiro Kodani , Kenichi Chikamori , Yukio Hosomi , Satoshi Hara , Yosuke Kawashima , Shoichi Kuyama , Yuji Shibata , Hibiki Udagawa , Tetsuya Sakai , Eri Sugiyama , Kaname Nosaki , Yoshitaka Zenke , Shigeki Umemura , Kiyotaka Yoh , Koichi Goto

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr 8628)

DOI

10.1200/JCO.2024.42.16_suppl.8628

Abstract #

8628

Poster Bd #

492

Abstract Disclosures

Similar Posters

First Author: Melissa Lynne Johnson

First Author: James Chih-Hsin Yang

First Author: Jonathan W. Riess